Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab-Reference-Cited by-同舟云学术

Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab

Published:2015-10 Issue: Volume:287 Page:29-30
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Mealy Maureen A.,Levy Michael

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference10 articles.

1. Early-onset neutropenia induced by rituximab in a patient with lupus nephritis and hemolytic anemia;Arroyo-Ávila;Case Rep. Rheumatol.,2015

2. Early onset neutropenia after rituximab in lupus nephritis;Enríquez;Clin. Exp. Rheumatol.,2007

3. Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients;Goh;Br. J. Dermatol.,2007

4. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases;Gottenberg;Ann. Rheum. Dis.,2005

5. Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence;Jacob;Mult. Scler.,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on the Incidence, Risk Factors and Mechanisms of Rituximab- Associated Neutropenia;Archives of Medical Science;2022-09-15

2. ALSUntangled #67: rituximab;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2022-09-15

3. Neuromyelitis optica;Nature Reviews Disease Primers;2020-10-22

4. Rituximab in neurological disease: principles, evidence and practice;Practical Neurology;2018-11-29

5. Early-onset neutropenia after rituximab therapy for bullous pemphigoid;Clinical and Experimental Dermatology;2018-08-27